These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3710294)

  • 1. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.
    Dahan R; Houlbert D; Caulin C; Cuzin E; Viltart C; Woler M; Segrestaa JM
    Haemostasis; 1986; 16(2):159-64. PubMed ID: 3710294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications.
    Bergqvist D; Burmark US; Frisell J; Hallböök T; Lindblad B; Risberg B; Törngren S; Wallin G
    Haemostasis; 1986; 16 Suppl 2():11-8. PubMed ID: 3744131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
    Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
    Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy.
    Vandendris M; Kutnowski M; Futeral B; Gianakopoulos X; Kraytman M; Gregoir W
    Urol Res; 1980; 8(4):219-21. PubMed ID: 7013228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.
    Taberner DA; Poller L; Burslem RW; Jones JB
    Br Med J; 1978 Feb; 1(6108):272-4. PubMed ID: 340005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M
    N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Turpie AG; Gent M; Côte R; Levine MN; Ginsberg JS; Powers PJ; Leclerc J; Geerts W; Jay R; Neemeh J
    Ann Intern Med; 1992 Sep; 117(5):353-7. PubMed ID: 1503326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group.
    Liezorovicz A; Picolet H; Peyrieux JC; Boissel JP
    Br J Surg; 1991 Apr; 78(4):412-6. PubMed ID: 1851649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
    Dumas R; Woitinas F; Kutnowski M; Nikolic I; Berberich R; Abedinpour F; Zoeckler S; Gregoire F; Jerkovic M; Egberts JF
    Age Ageing; 1994 Nov; 23(6):512-6. PubMed ID: 9231947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of deep vein thrombosis in medical patients by low-dose heparin.
    Belch JJ; Lowe GD; Ward AG; Forbes CD; Prentice CR
    Scott Med J; 1981 Apr; 26(2):115-7. PubMed ID: 7291971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.
    Onarheim H; Lund T; Heimdal A; Arnesjø B
    Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery.
    Speziale F; Verardi S; Taurino M; Nicolini G; Rizzo L; Fiorani P; Palazzini E
    Pharmatherapeutica; 1988; 5(4):261-8. PubMed ID: 3174726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of postoperative deep-vein thrombosis by low-dose heparin in urological surgery. A double-blind, randomised study.
    Kutnowski M; Vandendris M; Steinberger R; Kraytman M
    Urol Res; 1977; 5(3):123-5. PubMed ID: 919112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
    Harenberg J; Roebruck P; Heene DL
    Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.